The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Trends in the incidence of testicular germ cell tumors in the United States
Open accessAbstract
BACKGROUND: Recent reports have suggested that the increasing rates of testicular germ cell tumors in some populations have begun to plateau. This study was conducted to examine whether rates among white men in the United States have begun to stabilize and whether rates among black men in the United States have remained low. METHODS: Testicular germ cell tumor incidence data from in the Surveillance, Epidemiology, and End Results Program were analyzed for the years 1973–1998. Trends were examined separately for seminoma and nonseminoma. Using age‐period‐cohort analyses with 5‐year age intervals and 5‐year calendar‐period intervals, changes in the slope of the trends in birth‐cohort and calendar‐period effects were examined. RESULTS: Among white men, rates of seminoma continued to increase, but the rate of increase steadily declined throughout the 26‐year time span. Nonseminoma rates among whites increased more slowly during the first three time intervals, then plateaued in the final interval. Rates of both seminoma and nonseminoma in black men fluctuated throughout the first three time intervals. In the final interval, the rates of seminoma increased almost 100%, whereas the rates of nonseminoma increased more modestly. Age‐period‐cohort modeling of the incidence data in white men found that, whereas the dominant effect was that of birth cohort, there also was a period effect. CONCLUSIONS: Among white men in the United States, the incidence of testicular germ cell tumors varied by histology, with a continuing increase in risk only for seminoma. Among black men in the United States, the surprising increases seen between 1988 and 1998 were likely to be a calendar‐period effect. Cancer 2003;97:63–70. Published 2003 by the American Cancer Society. DOI 10.1002/cncr.11054
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer mortality for selected sites in 24 countries
栗原, 登., & 瀬木, 三. (1960) · Medical Entomology and Zoology · Cited by 871
Association of Cancer With AIDS-Related Immunosuppression in Adults
Frisch, M. (2001) · JAMA · doi:10.1001/jama.285.13.1736 · Cited by 821
SKAKKEBÆK, N. E., BERTHELSEN, J. G., GIWERCMAN, A., & MÜLLER, J. (1987) · International Journal of Andrology · doi:10.1111/j.1365-2605.1987.tb00161.x · Cited by 741
International trends in rates of hypospadias and cryptorchidism.
Paulozzi, L. J. (1999) · Environmental Health Perspectives · doi:10.1289/ehp.99107297 · Cited by 487
Increase in Testicular Cancer Incidence in Six European Countries: a Birth Cohort Phenomenon
Bergström, R., Adami, H.-O., Möhner, M., Zatonski, W., Storm, H., Ekbom, A., Tretli, S., Teppo, L., Akre, O., & Hakulinen, T. (1996) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/88.11.727 · Cited by 439
Miehlke, S., Kirsch, C., Agha‐Amiri, K., Günther, T., Lehn, N., Malfertheiner, P., Stolte, M., Ehninger, G., & Bayerdörffer, E. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000801)87:3<438::aid-ijc20>3.0.co;2-1 · Cited by 200
Moller, H., & Skakkebæk, N. E. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960503)66:3<287::aid-ijc2>3.0.co;2-v · Cited by 192
Møller, H., & Skakkeb\sgmaelig;k, N. E. (1997) · Cancer Causes & Control · doi:10.1023/a:1018472530653 · Cited by 178
HORMONAL RISK FACTORS IN TESTICULAR CANCER A CASE-CONTROL STUDY
MOSS, A. R., OSMOND, D., BACCHETTI, P., TORTI, F. M., & GURGIN, V. (1986) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114369 · Cited by 176
The outcome of extreme prematurity
Lorenz, J. M. (2001) · Seminars in Perinatology · doi:10.1053/sper.2001.27164 · Cited by 175
Graphical Presentation of Trends in Rates
Devesa, S. S., Donaldson, J., & Fears, T. (1995) · American Journal of Epidemiology · doi:10.1093/aje/141.4.300 · Cited by 159
Self-citationRISING RISK OF TESTICULAR CANCER BY BIRTH COHORT IN THE UNITED STATES FROM 1973 TO 1995
McKIERNAN, J. M., Goluboff, E. T., Liberson, G. L., et al. (1999) · The Journal of Urology · doi:10.1016/s0022-5347(05)68560-6 · Cited by 133
ARTICLES: Testicular Nonseminoma and Seminoma in Relation to Perinatal Characteristics
Akre, O., Ekbom, A., Hsieh, C.-C., et al. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.13.883 · Cited by 130
Genital Anomalies and Risk for Testicular Cancer in Danish Men
PRENER, A., Engholm, G., & Jensen, O. M. (1996) · Epidemiology · doi:10.1097/00001648-199601000-00004 · Cited by 127
Testicular cancer and antecedent diseases
Swerdlow, A. J., Huttly, S., & Smith, P. G. (1987) · British Journal of Cancer · doi:10.1038/bjc.1987.20 · Cited by 124
Evaluation of birth cohort patterns in population disease rates.
Tarone, R., & Chu, K. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008661 · Cited by 115
Self-citationTrends in incidence of testicular cancer in Norway 1955–1992
Wanderås, E. H., Tretli, S., & Fossra, S. D. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(95)00321-5 · Cited by 111
Projections of Lung Cancer Mortality in the United States: 1985-20251
Brown, C. C., & Kessler, L. G. (1988) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/80.1.43 · Cited by 107
Zheng, T., Holford, T. R., Ma, Z., Ward, B. A., Flannery, J., & Boyle, P. (1996) · International Journal of Cancer · Cited by 103
Trends in the incidence of testicular germ cell cancer in Ontario by histologic subgroup, 1964-1996.
Weir, H. K., Marrett, L. D., & Moravan, V. (1999) · Europe PMC (PubMed Central) · Cited by 76
Risk factors for testicular germ cell tumours by histological tumour type
on behalf of the United Kingdom Testicular Cancer Study Group, Coupland, C. A. C., Chilvers, C. E. D., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690611 · Cited by 73
Increasing incidence of testicular cancer — birth cohort effects
Ekbom, A., & Akre, O. (1998) · Apmis · doi:10.1111/j.1699-0463.1998.tb01340.x · Cited by 68
Time trends and occupational differences in cancer of the testis in New Zealand
Pearce, N., Sheppard, R. A., Howard, J., Fraser, J. D., & Lilley, B. M. (1987) · Cancer · doi:10.1002/1097-0142(19870501)59:9<1677::aid-cncr2820590926>3.0.co;2-q · Cited by 67
Trebling of the incidence of testicular cancer in victoria, australia (1950–1985)
Stone, J. M., Cruickshank, D. G., Sandeman, T. F., & Matthews, J. P. (1991) · Cancer · Cited by 65
Liu, S., Semenciw, R. M., Waters, C., Wen, S. W., Mery, L., & Mao, Y. (2000) · International Journal of Epidemiology · doi:10.1093/ije/29.5.826 · Cited by 50
Cited by
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
Diamanti-Kandarakis, E., Bourguignon, J.-P., Giudice, L. C., Hauser, R., Prins, G. S., Soto, A. M., Zoeller, R. T., & Gore, A. C. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0002 · Cited by 4,585
Sturgeon, C. M., Duffy, M. J., Stenman, U.-H., Lilja, H., Brünner, N., Chan, D. W., Babaian, R., Bast, R. C., Dowell, B., Esteva, F. J., et al. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.105601 · Cited by 1,129
Skakkebaek, N. E., Rajpert-De Meyts, E., Buck Louis, G. M., Toppari, J., Andersson, A.-M., Eisenberg, M. L., Jensen, T. K., Jørgensen, N., Swan, S. H., Sapra, K. J., et al. (2016) · Physiological Reviews · doi:10.1152/physrev.00017.2015 · Cited by 977
Testicular dysgenesis syndrome: mechanistic insights and potential new downstream effects
Sharpe, R. M., & Skakkebaek, N. E. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.12.026 · Cited by 446
Clinical epidemiology of testicular germ cell tumors
Dieckmann, K.-P., & Pichlmeier, U. (2004) · World Journal of Urology · doi:10.1007/s00345-004-0398-8 · Cited by 339
Metadata
- Authors
- McGlynn, K. A., Devesa, S. S., Sigurdson, A. J., Brown, L. M., Tsao, L., & Tarone, R. E.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2002-12-18
- Volume
- 97
- Issue
- 1
- Pages
- 63-70
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2115709003
- Cited by
- 338
- References
- 25
- FWCI
- 9.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.